Holen Sie sich die Stockscreener-App
1.415
2.54%
0.035
Biomea Fusion Inc Aktie (BMEA) Neueste Nachrichten
Biomea Fusion Inc Financial Disclosures & SEC Filings - TradingView
Price to earnings forward of Biomea Fusion, Inc. – NASDAQ:BMEA - TradingView
Price to sales forward of Biomea Fusion, Inc. – NASDAQ:BMEA - TradingView
Price to book forward of Biomea Fusion, Inc. – NASDAQ:BMEA - TradingView
Insiders Buying Biomea Fusion Might Wish They Invested More, Stock Gains 12% - simplywall.st
Enterprise value to EBITDA forward of Biomea Fusion, Inc. – NASDAQ:BMEA - TradingView
Enterprise value to EBIT forward of Biomea Fusion, Inc. – NASDAQ:BMEA - TradingView
Biomea Fusion Inc Actuals & Estimates (NASDAQ:BMEA) - TradingView
COVALENT-112 Phase II data boost momentum for ico, Biomea Fusion pushes first-in-class strategy - Traders Union
BMEA Forecast — Price Target — Prediction for 2027 - TradingView
H.C. Wainwright Maintains Biomea Fusion(BMEA.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Biomea Fusion forges new industry ties at BIO International Convention - Traders Union
Biomea Fusion Inc (BMEA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biomea Fusion Inc (BMEA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Biomea Fusion Inc (BMEA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Biomea Fusion Inc (BMEA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biomea Fusion Inc (BMEA) Institutional Confidence - TradingKey
Biomea Fusion Inc (BMEA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Team Fusion pinpoints this year leading trends at ADA2026 event - Traders Union
Biomea Fusion Inc (BMEA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biomea Fusion Inc (BMEA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biomea Fusion Inc (BMEA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Number of shareholders of Biomea Fusion, Inc. – NASDAQ:BMEA - TradingView
Biomea Fusion Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Cost DisciplineOne-Time Gain Impact - newsline.com
Biomea Fusion Inc. Q1 2026 Earnings: EPS Beat on Cost Discipline as Biotech Advances PipelinePost-Announcement Reaction - newsline.com
[Form 4] Biomea Fusion, Inc. Insider Trading Activity - Stock Titan
Biomea Fusion (BMEA) director granted 196,299 stock options at $1.15 exercise price - Stock Titan
Biomea Fusion (BMEA) director Ray Sumita granted 196,299 stock options - Stock Titan
Biomea Fusion (BMEA) director receives 173,711-share stock option grant at $1.15 - Stock Titan
Citi Maintains Biomea Fusion(BMEA.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Biomea Fusion (NASDAQ: BMEA) details 2026 director and auditor votes - Stock Titan
BMEA: Directors and auditors were approved by majority vote, with results to be filed with the SEC - TradingView
BMEA: All proposals, including director elections and auditor ratification, were approved - TradingView
Piper Sandler Maintains Biomea Fusion(BMEA.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Biomea Fusion, Inc. (BMEA) Presents at American Diabetes Association (ADA) 86th Scientific SessionsSlideshow - Seeking Alpha
BMEA Q1 2026 Earnings: EPS Beat on Controlled Spending Overshadowed by Pipeline ConcernsAnalyst Drop Coverage - newsline.com
Biomea Fusion unveils new icovamenib data showing durable insulin secretion gains in T1D and T2D - Traders Union
Biomea Fusion shows promising diabetes and obesity drug data, expands Phase I study for weight loss therapy. - Pluang
Biomea Fusion Presents Promising Clinical Data for Icovamenib and Expands Phase I Study of BMF-650 at ADA 2026 - Quiver Quantitative
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association ('ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study - The Manila Times
Biomea Fusion Says Icovamenib Data Show Muscle Preservation And Fat Reduction In Obesity And Diabetes - TradingView
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study - GlobeNewswire
New diabetes pills show insulin gains and weight-loss potential at ADA - Stock Titan
BMEA: Phase II diabetes trials for a novel menin inhibitor target non-chronic, restorative therapy - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Biomea Fusion to study icovamenib with semaglutide for weight loss - Investing.com UK
Icovamenib GLP-1 therapy combination evaluated in Biomea Fusion academic study - Traders Union
Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity - Investing News Network
Biomea Fusion to study icovamenib with semaglutide for weight loss By Investing.com - Investing.com South Africa
Biomea Fusion Announces Research Collaboration with - GlobeNewswire
Biomea Fusion icovamenib abstracts chosen for late-breaking poster presentations at diabetes conference - Traders Union
Biomea Fusion Q1 2026 Earnings: EPS Beats Estimates Despite No RevenueReturn On Assets - newsline.com
Biomea Fusion (BMEA) Holds Steady at $1.38, Testing Support as Traders Weigh Next MoveIsland Reversal - newsline.com
Biomea Fusion advances COVALENT-211 and COVALENT-212 research in type 2 diabetes - Traders Union
BMEA Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Progress in Clinical PipelineConsensus Miss Rate - dars.gov.et
BMEABiomea Fusion Inc Stock Price and Quote - Finviz
Biomea Fusion (BMEA) Stages a Rebound: Testing Key Resistance After a +3.65% GainDaily Profile - thelegaladvocate.com
Biomea Fusion Shares Surge Over 6% as BMEA Tests Key ResistanceRisk Reward Setups - newsline.com
Biomea Fusion Q1 2026 Earnings: Narrowed Loss per Share Exceeds Expectations as Pipeline Progress Drives Stock UptickEarnings Quality Score - thelegaladvocate.com
Biomea Fusion Q1 2026 Earnings: Narrower-Than-Expected Loss Fuels Positive Market ResponseEarnings Season Outlook - newsline.com
BMEA Stock Price, Quote & Chart | BIOMEA FUSION INC (NASDAQ:BMEA) - ChartMill
Biomea Fusion, Inc.Common Stock (NQ: BMEA - FinancialContent
1.95%
2.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):